EAN 2023 | Strategies for advancing precision therapy in epilepsy

To advance precision therapy for epileptic conditions, Guido Rubboli, MD, University of Copenhagen, Copenhagen, Denmark, proposes several key research areas. These include a better understanding of the pathophysiological mechanisms linked to causative genes in epilepsy, prioritizing natural history studies to inform the assessment of newer compounds, and creating more accurate models that consider the differences between human and animal systems. Additionally, refining assessment measures for drug effects is essential. Dr. Rubboli also emphasizes the importance of enhanced collaboration between patients and scientists for progress in precision therapy for epilepsy. This interview took place at the European Academy of Neurology (EAN) 2023 Congress in Budapest, Hungary.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.